‘It's comfortable and cosy': why working from bed is key to this agent's success
by Emma Dooney
A travel agency owner has called for more compassion for homeworkers, arguing that she manages her company more efficiently from her house – and indeed her bed – than she ever could from an office.
Paula Hansen runs World Accessible Holidays, which specialises in travel for disabled clients, entirely from her home in Wales. Like many agents, she believes a remote model enables her to maintain a healthier work-life balance and be overall more productive.
But for Hansen, homeworking isn't just a perk – it's a necessity.
The mother of one lives with fibromyalgia, a chronic disorder that causes pain in muscles and soft tissues all over the body. Other symptoms include fatigue, brain fog and sleep disturbances, all of which can significantly affect the individual's ability to work – and makes working from an office almost impossible.
In 2023, 136,000 claimants of PIP (Personal Independence Payment) listed fibromyalgia as their main disabling condition. Many people in employment may also require additional sick leave and/or reduced hours, due to the severe and often volatile nature of their symptoms.
But Hansen is determined not to let her fibromyalgia limit her potential as a business woman. Three years on from her diagnosis, she has developed a sturdy kit of tools for maintaining her productivity – including working from bed.
'Why shouldn't you work from bed?' Hansen tells TTG Luxury. 'It's comfortable and cosy, and you're probably working more effectively because you're relaxed.'
The self-proclaimed 'bedpreneur' says that working from bed is also preferable to a desk, which tends to flare up her symptoms: 'All of the pain from my fibromyalgia is from the hips upwards, so my back will hurt if I'm sitting on a chair for too long.'
Hansen's work hours are also atypical, beginning at around 10am and ending at nearly midnight. 'My pain levels are highest in the morning, so I'll do some hours after 10am, and then if I'm tired, I'll go and have a sleep, and then resume work when I wake up,' she explains.
'So it is more like a nine to 11 schedule, with lots of sleep breaks in between.' She also uses meditation and ice packs, along with painkillers when necessary, to further alleviate her symptoms.
'Why shouldn't you work from bed? It's comfortable and cosy'
As well as helping her to manage pain more effectively, working from home has also been hugely beneficial for Hansen's concentration.
Without the usual office disruptions, she says she can focus for longer and thus, complete tasks faster. This lack of distractions can be especially valuable for people with fibromyalgia, 80% of whom will experience issues with memory and attention.
While Hansen's condition has undoubtedly made work more challenging, it has also instilled in her a great deal of empathy for her clients.
The Cardiff native knows all too well the obstacles of travelling with mobility issues; as well as causing extreme tiredness, her fibromyalgia prevents her from sitting in one position for extended periods of time, which makes driving and flying particularly difficult.
Hansen also has a teenage son with cerebral palsy, a neurological condition that causes muscle weakness and impaired mobility. While Evan can walk short distances, he requires a wheelchair and is unable to travel without assistance. Flying can be especially 'nightmarish', says Hansen, due to the lack of consideration from other passengers boarding the plane.
It's this first-hand experience of disability that has given her the determination to continue advocating for disabled travellers – even when she's in severe pain.
Hansen arranges all types of trips for her clients, from city breaks and beach holidays to safaris and honeymoons. To achieve this, she partners with specialist suppliers who can provide medical equipment, adapted transport and accessible accommodation.
The disability of her customers varies, but each one has a dream of travelling without barriers. For many, it's their first holiday after a serious illness or accident. The additional requirements create extra work for Hansen, but having witnessed the life-changing power of travel for individuals with disabilities, she says 'it's all worthwhile'.
'When you have a client tell you they've gotten into the sea for the first time because you've recommended a hotel with a sea track, that is much better than just someone saying, 'I've had a great holiday,'' she explains. 'It's so rewarding.'
Previous Article P&O Cruises unveils new ship visit programme with 650 agent places available Next Article Finalists revealed for TTG Travel Industry Awards 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
14 minutes ago
- The Independent
Nearly 600 heat-related deaths expected in UK heatwave, researchers estimate
Nearly 600 people in England and Wales are predicted to die as a result of this week's heatwave, researchers have found. Experts at the London School of Hygiene and Tropical Medicine (LSHTM) and Imperial College London used decades of UK data to predict excess mortality during the hot temperatures from Thursday to Sunday. Their study, released on Saturday, forecasts that around 570 people will die because of the heat over the four days. The excess deaths are estimated to peak at 266 on Saturday when the heat will be at its most intense. London is predicted to have the greatest number of excess deaths with 129. The researchers said their assessment highlights how extreme heat poses a growing threat to public health in the UK. It follows a World Weather Attribution (WWA) research group study published on Friday which found the heatwave has been made about 100 times more likely and 2-4C hotter due to climate change. Dr Garyfallos Konstantinoudis, lecturer at the Grantham Institute at Imperial College London, said: 'Heatwaves are silent killers – people who lose their lives in them typically have pre-existing health conditions and rarely have heat listed as a contributing cause of death. 'This real-time analysis reveals the hidden toll of heatwaves and we want it to help raise the alarm. 'Heatwaves are an underappreciated threat in the UK and they're becoming more dangerous with climate change.' Dr Konstantinoudis warned that people should follow heat-health advice this weekend and check on older people, particularly those living alone. Temperatures had been forecast to hit 32C across the South East on Saturday and had already reached that level on Thursday in London. The UK Health Security Agency issued an amber heat-health alert covering all of England to warn vulnerable populations of the health risks, including 'a rise in deaths'. Dozens of people required treatment for heat-related illness at Royal Ascot on Thursday. The researchers used findings from published research on the relationship between heat and the number of daily deaths, regardless of the cause, in 34,753 areas of England and Wales. They combined these with high-resolution weather forecasts from the Copernicus climate change service to estimate how many heat-related deaths will occur. They estimated that 114 excess deaths would have occurred on Thursday, 152 on Friday, 266 on Saturday and 37 deaths on Sunday, when temperatures will fall to the mid-20s. People above 65 are expected to be hardest hit, with 488 of the estimated excess deaths, the report said. But the experts also warn that heat can be life-threatening for all ages, with 82 deaths estimated for people aged under 65. They also note that the analysis does not account for the effect of the heatwave occurring early in summer before people are acclimatised to hot temperatures, meaning deaths could be underestimated. A recent report by the UK Climate Change Committee estimated that heat-related deaths could rise to more than 10,000 in an average year by 2050 if fossil fuel burning causes warming to reach 2C. UN scientists warned this week that the world is in 'crunch time' to limit warming and has three years left to prevent global average temperature rises exceeding 1.5C. Professor Antonio Gasparrini, of the LSHTM, said: 'Increases of just a degree or two can be the difference between life and death. 'Every fraction of a degree of warming will cause more hospital admissions and heat deaths, putting more strain on the NHS.' Dr Malcolm Mistry, assistant professor at the LSHTM, said: 'Exposure to temperatures in the high 20s or low 30s may not seem dangerous, but they can be fatal, particularly for people aged over 65, infants, pregnant people and those with pre-existing health conditions. 'Unless effective mitigation and adaptive measures are put in place in the coming years, the risk of large heat-related death events is set to increase in the UK – we have a large ageing population and warming is expected to increase to 2C by 2050 and as high as 3C this century.' Dr Lorna Powell, an NHS urgent care doctor in east London who was not involved in the study, said: 'We are seeing cases of heat-related illnesses rising in our urgent care departments. 'Heat exhaustion can quickly trigger more serious illnesses as dehydration sets in and the cardiovascular system becomes overwhelmed.'
Daily Mail
18 minutes ago
- Daily Mail
Every newborn baby in the UK will have DNA screening in NHS 'revolution' to battle killer diseases, Wes Streeting reveals
Every newborn baby in the UK will have a DNA screening as part of an NHS 'revolution' to battle killer diseases. The health secretary Wes Streeting said new technology in areas such as genomics would help 'leapfrog' illnesses. The Government is set to pour £650 million into DNA technology in an effort to treat serious illnesses before they become a problem. The investment in genomics is expected to support the Government's 10-year plan for the NHS, which will see a greater focus on technology and prevention. Mr Streeting told The Telegraph: 'The revolution in medical science means that we can transform the NHS over the coming decade, from a service which diagnoses and treats ill health to one that predicts and prevents it. 'Genomics presents us with the opportunity to leapfrog disease, so we're in front of it rather than reacting to it.' Mr Streeting has previously spoken about his desire to make the NHS more preventative, reducing rates of serious illness and saving money in the process. The plan is also likely to see a greater role for artificial intelligence and other technologies to predict illness and allow treatment or medication to be offered much earlier. Mr Streeting has previously spoken about his desire to make the NHS more preventative, reducing rates of serious illness and saving money in the process. The plan is also likely to see a greater role for artificial intelligence and other technologies to predict illness and allow treatment or medication to be offered much earlier. He added: 'With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives.' Along with a greater focus on prevention, the Government's 10-year plan is expected to include Mr Streeting's two other 'shifts' in the NHS. That will see a shift away from hospitals towards more community-focused care, and from analogue to digital services. It follows Chancellor Rachel Reeves' announcement that the Government would increase NHS funding by £29 billion per year in real terms over the next three years as it tries to cut waiting lists in line with its election promises.
The Independent
25 minutes ago
- The Independent
Weight loss jab could be used to treat migraines
Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion. Researchers have discovered, GLP-1 drug liraglutide, commonly used to treat diabetes, has the potential to significantly reduce migraine frequency. Migraines affect approximately 6 million people in the UK, according to the NHS. Attacks can last for three days causing pain, nausea, vomiting, dizziness and sensitivity to light, sound and smells. Researchers at the Headache Centre of the University of Naples gave 26 adults with obesity and chronic migraines the drug liraglutide. The study presented at the European Academy of Neurology (EAN) Congress 2025, found those who had the drug reported an average of 11 fewer headache days per month. Participants also experienced meaningful improvements in quality of life, work, study, and social functioning within just two weeks of taking the drug. 'Most patients felt better within the first two weeks and reported quality of life improved significantly', said lead researcher Dr Simone Braca. 'The benefit lasted for the full three-month observation period, even though weight loss was modest and statistically non-significant.' Growing evidence has linked subtle increases in intracranial pressure to migraine attacks. It's caused by a rise in the pressure of cerebrospinal fluid – which surrounds the brain and spinal cord. This increase in pressure can happen because of a severe head injury, stroke, a brain tumour or high blood pressure. But GLP-1-receptor agonists such as liraglutide reduce cerebrospinal fluid secretion and have already proved effective in treating idiopathic intracranial hypertension (IIH). Patients in the study were screened to exclude papilledema (optic disc swelling resulting from increased intracranial pressure) and sixth nerve palsy, ruling out IIH. Dr Braca and colleagues believe GLP-1 drugs may reduce the release of CGRP (calcitonin gene-related peptide), a key molecule behind migraines. 'We think that, by modulating cerebrospinal fluid pressure and reducing intracranial venous sinuses compression, these drugs produce a decrease in the release of calcitonin gene-related peptide (CGRP), a key migraine-promoting peptide', Dr Braca said. 'That would pose intracranial pressure control as a brand-new, pharmacologically targetable pathway.' Given liraglutide's established use in type 2 diabetes and obesity, it may represent a promising case of drug repurposing in neurology, study authors said.
